OnEMI Technology Solutions IPO
India’s fast-growing digital lending fintech behind Kissht and Ring — going public with a ₹925.92 crore issue. Here’s everything you need to know before applying.
Price Band
₹162–171
per share
Issue Size
₹925.92 Cr
Fresh + OFS
Min Invest
₹14,877
87 Shares / 1 Lot
Listing Date
May 8
NSE & BSE
IPO timeline
Apr 30
Opens
May 5
Closes
May 6
Allotment
May 7
Refund
May 8
Listing
About the company
OnEMI Technology Solutions Pvt Ltd, which operates the fintech platform Kissht and the app Ring, was co-founded by Ranvir Singh and Krishnan Vishwanathan. Ranvir Singh serves as the Founder & CEO. The company is a digital lending platform providing instant credit solutions in India.
Registered Users
63.73 Million
Active Customers
11.17 Million
Total AUM
₹59,557.53 Cr
Play Store
4.7 ★ Rating
Company Financials
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 3,568.78 | 2,701.10 | 1,796.53 | 1,275.20 |
| Total Income | 1,583.93 | 1,352.69 | 1,700.30 | 1,001.51 |
| Profit After Tax | 199.27 | 160.62 | 197.29 | 27.67 |
| EBITDA | 488.45 | 403.37 | 358.96 | 97.71 |
| NET Worth | 1,254.34 | 1,005.99 | 804.57 | 566.23 |
| Reserves and Surplus | 1,242.32 | 995.32 | 794.50 | 556.17 |
| Total Borrowing | 2,047.52 | 1,507.58 | 784.30 | 387.89 |
Amount in ₹ Crore
Objectives of IPO
- Augmenting the capital base of Subsidiary, Si Creva, to meet its future capital requirements arising out of the growth of Subsidiary, Si Crevas, business
- General Corporate Purposes
IPO details
IPO Date
30 Apr to 5 May, 2026
Listing Date
Fri, May 8, 2026
Face Value
₹1 per share
Price Band
₹162 to ₹171
Lot Size
87 Shares
Sale Type
Fresh capital cum OFS
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
5,41,47,390 shares
(agg. up to ₹926 Cr)
Fresh Issue
4,97,07,602 shares
(agg. up to ₹850 Cr)
Offer for Sale
44,39,788 shares
(agg. up to ₹76 Cr)
Pre Issue Holding
11,87,75,420 shares
Post Issue Holding
16,84,83,022 shares
Source – SEBI, Chittorgarh
To check allotment, click here


